The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for April 22, 2022
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA

For All News & Notes Subscribers: At the end of April, we will move to a new platform to host and deliver this newsletter.  To keep our subscriber database up to date, we would like you to update your profile, which can be done here.   It will take just a minute of your time.  We will keep the same well-liked format and will continue sending it out on Friday mornings. Thanks for subscribing – we appreciate it!


Brakke Consulting News
Equine MegaStudy V
Brakke Recruiting – VP Sales, Marketing & Business Development

Earnings News

Other News
Boehringer Ingelheim (expansion)
Boehringer Ingelheim (RenuTend)
Camp Bow Wow
Ceva Bussan Animal Health KK
CureLab Veterinary
Enso Discoveries
Genvax Technologies
Mitsui & Co
Kensington Capital Partners
PetMed Express
People for Pets
Real Pet Food Company
Vidium Animal Health

Brakke Consulting


Pet Flavors, Inc. of Melbourne, FL seeks a seasoned animal health professional to fill this key commercial position in their small but highly successful company. The company markets palatants to animal health pharmaceutical developers. The company seeks candidates with strong commercial experience in the overall drug development process and good commercial contacts among the major companies that developer and register oral product for companion animals. A Bachelor’s degree is required, an MBA is a plus. The candidate must be self-sufficient and be able to operate independently   in the company known for its connected, small company culture. Relocation to Melbourne, FL strongly preferred. Travel required, 25-50%. Compensation $250k, plus 20% bonus eligibility and equity potential.

Click here for more information.


  • Virbac reported results for the first quarter of 2022. Revenue was EUR 318 million ($344 million), a 19% increase with respect to the same period in 2021 (+16% at constant exchange rates). US revenue increased by 26% (17.5% at constant exchange rates), benefitting from strong sales of new products launched in 2021, as well as external parasiticides. (Globenewswire)
  • Nestlé reported results for the first quarter of 2022. PetCare sales were CHF 4,109 million ($4,315 million), an increase of 13.5% compared to the prior-year quarter. (company website

AHN Forum “Treating Canine Lymphoma – Breakthrough Therapies for both Pet and Pet Family Members ”
May 24th,  4:00 – 6:00 p.m.

Join us on May 24th for an Animal Health and Nutrition forum at the North Carolina Biotechnology Center in RTP. Recent advances in immunotherapy offer an opportunity to tackle many of the most difficult human cancers. However, many questions remain to be answered. Dogs, often suffering from the same diseases, also lack sufficient life-saving treatments. Now as we develop therapies to treat our companions, we have the opportunity to learn how to treat ourselves.

Click here to register.


  • Zoetis announced it has added artificial intelligence (AI) blood smear testing to its Vetscan Imagyst platform. Veterinarians also have the option to submit a digital blood smear image for expert review by a clinical pathologist in its virtual lab, without rescanning the slide. (IHS Markit Connect)
  • Merck Animal Health introduced two new tools to bring cattle health information to cattle producers’ fingertips. The Merck Animal Health Herd Health Manager guides producers and their veterinarians to build a customized herd health plan, and then encourages them to print out a record to share the information at marketing. The Merck Animal Health “Merck Feedlot Diseases Atlas” app shares comprehensive photos of diseases that impact feedlot cattle. (company press release)
  • Boehringer Ingelheim announced a $57 million expansion of its Animal Health Global Innovation center in Athens, Georgia. The investment will increase laboratory space and bring additional research and development capabilities and activities to the site. (
  • Elanco announced plans for its new global headquarters in Indianapolis. The planned 220,000-square-foot office structure and connected facilities will be designed to serve as the foundation of a planned animal health epicenter in Indianapolis. The campus is being developed in collaboration with AgriNovus, the state of Indiana’s food and agriculture initiative, and business incubator High Alpha. (company press release)
  • Hill’s Pet Nutrition announced a relaunch of its Prescription Diet pet food line on Feb. 24. The relaunch will focus on new formulations, packaging redesigns and stronger veterinary outreach. The relaunch of Hill’s Prescription Diet will begin in Europe before rolling out to the United States and the rest of the world in 2022. (Petfoodprocessing)
  • Enso Discoveries, LLC, announced it has introduced the patent-pending Rebound PRP Supra Kit, capable of processing 60 ml of whole blood. The new kit enables veterinarians to treat multiple injuries with multiple joint injections in larger animals with a single blood draw. (PRweb)
  • Vidium Animal Health announced it has added specialty pathology services to its in-house diagnostic testing capabilities. The company’s pathology services, including histopathology and cytology, are available for small and large animals. (Vet Advantage)
  • Genvax Technologies announced it has been awarded a $145,000 grant from the Foundation for Food & Agriculture Research (FFAR) to develop a self-amplifying messenger RNA (saRNA) vaccine for African swine fever (ASF) in collaboration with the USDA’s Agricultural Research Services Plum Island Animal Disease Center (USDA-ARS-PIADC). Matching funds were provided by Genvax Technologies for a total $290,000 investment in innovative ASF vaccine research. Researchers will test the vaccine at USDA-ARS-PIADC. (Porkbusiness)
  • The University of Camerino (UniCam) has extended its strategic business partnership with CureLab Oncology Inc. to develop anti-cancer immunotherapy for humans, and has signed a similar agreement with CureLab Veterinary , to reapply this medicine for treatment of companion animals. CureLab Veterinary licensed the DNA plasmid p62 IP for application in cats, dogs, and horses after the scientific team successfully treated dogs with mammary cancer. (
  • Vetster announced it has raised a total of $30 million in its oversubscribed Series B round. The investment is led by Kensington Capital Partners; PetMed Express, Inc. joins the round as an investor and strategic partner. (Businesswire)
  • To kick off National Pet Month, Amazon is celebrating with the first ever Amazon Pet Day. On May 2, Amazon will offer 24 hours of savings to all US shoppers on a wide selection of deals across categories such as home, pets, and electronics. Prime members will also enjoy special pet-based offers; and customers can simultaneously shop and support a pet charity through AmazonSmile. (Pet Business)
  • Camp Bow Wow announced it has opened its first Kentucky location in Lexington Kentucky; marking Camp Bow Wow’s 200th camp. (Pet Business)
  • EU Boehringer Ingelheim announced the European approval for RenuTend, the first product licensed to improve healing of tendon and suspensory ligament injuries in horses. RenuTend is a stem cell product administered by intralesional injection. (company press release)
  • JAPAN Ceva Sante Animale announced it has formed Ceva Bussan Animal Health KK, a joint venture with Mitsui & Co., Ltd. to accelerate expansion to Japan.  Mitsui has been a shareholder of Ceva since 2020. (company press release)
  • AUSTRALIA Real Pet Food Company announced an investment in plant-based and human-grade pet supplements company People for Pets. Financial terms were not disclosed. (GlobalPets)



  • WORLD – RESEARCH COLLABORATION The Pirbright Institute has partnered with the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO), focused on the prevention and control of infectious diseases. The pact will encourage knowledge exchange between the two institutes to increase the capacity for vaccine innovation and pandemic preparedness. (IHS Markit Connect)
  • US – DRAFT GUIDANCE The FDA announced the availability of draft Guidance for Industry #106 entitled “The Use of Published Literature in Support of New Animal Drug Approvals.” The document provides guidance to animal drug sponsors on specific areas of the approval process where the available scientific literature may be useful to support the approval of a new animal drug application, an abbreviated new animal drug application, or a conditionally approved new animal drug application. (FDA)
  • US – NARMS The FDA, in cooperation with the Centers for Disease Control and Prevention and the USDA’s Food Safety and Inspection Service, its partners in the National Antimicrobial Resistance Monitoring System, has released the NARMS Integrated Summary 2019. According to the NARMS data collected in 2019, the majority (78%) of Salmonella isolates collected from humans were not resistant to any of the antimicrobials tested under NARMS; the overall level of resistance remained relatively unchanged from 2018. None of the Salmonella or coli isolates from animals, animal products, or retail meats harbored any of the known colistin resistance genes. Fluoroquinolone resistance in Campylobacter continues to increase, and it is not clear what’s driving this trend. (Feedstuffs)
  • US – GENE EDITING Livestock and crop groups sent a letter to USDA renewing calls for the department to advance its own animal gene editing regulations. Currently, the FDA regulates the DNA of genetically modified animals as animal drugs.  (Feedstuffs)
  • US – VETERINARY EDUCATION Lyon College in Arkansas is developing plans for what will be the first veterinary school in the state.  Pending approval from the American Veterinary Medical Association’s Council on Education (COE), inaugural classes could start as early as 2024 or 2025.  The college has identified several potential locations in Little Rock and should finalize the location for the campus soon. (

Brakke Consulting


How has horse ownership and spending changed in the past 5 years?  Find out in the fifth edition of the Equine Market MegaStudy.  The study will be fielded in May with reports available in July/August 2022.

This highly popular survey includes over 400 brands of equine products in 19 categories. The study also measures readership of equine publications, catalogs and websites, and provides a wealth of information on horse owner demographics and segments.

The cost of the report is $17,500; orders placed by May 6 will receive a $1,500 discount.   For more information, or to order a study, contact project manager Lynn Fondon at or 336-396-3916.

Amazon this week announced its inaugural Amazon Pet Day, coming up the first week of May. Many of us in the industry may not think of Amazon as a key player in pet products, but a recent Packaged Facts report found that Amazon was the #1 source for online pet purchases, which they claim now represent nearly one-third of all pet product sales.

Amazon is known to drive increased sales on its platform on its annual Amazon Prime Day: according to one source, retailers enjoy at 20-30% bump in e-commerce sales on Prime Day. One can only imagine how much anticipation there is at those companies selling pet products through Amazon. Will competitors like Chewy, and offer similar deals on May 2, as has happened with Prime Day? Don’t be surprised if they do.

Lynn Fondon

Last week’s poll asked if your companies were changing their full year forecast after learning the first quarter results. Most of you (66%) said that the forecast wasn’t changing, but 21% said it was being lowered, and 14% said it was being raised.

This week

Veterinary clinic consolidation is ongoing, and gaining momentum.  So let’s hear how much of the market you think corporate clinics now represent.  Next week, we’ll report the results and then give you our own estimates.

What percent of the clinics in the US do you believe are owned by a corporate consolidator?

en_USEnglish (United States)